Antiarrhythmic drugs–clinical use and clinical decision making: a consensus document from the European Heart Rhythm Association (EHRA) and European Society of …

GA Dan, A Martinez-Rubio, S Agewall, G Boriani… - Ep …, 2018 - academic.oup.com
NSAT Non-sustained atrial tachycardia NSVT Non-sustained ventricular tachycardia PD
Pharmacodynamic P-GP P-glucoprotein PK Pharmacokinetic PM Pacemaker PVT …

JCS/JHRS 2020 guideline on pharmacotherapy of cardiac arrhythmias

K Ono, Y Iwasaki, M Akao, T Ikeda, K Ishii… - Circulation …, 2022 - jstage.jst.go.jp
The Japanese Circulation Society (JCS) published the “Guidelines for Pharmacological
Treatment of Arrhythmia” in 2004, and a revised edition was published in 2009. 1 Both …

Drug choices in the treatment of atrial fibrillation

JA Reiffel - The American journal of cardiology, 2000 - Elsevier
When considering therapy for atrial fibrillation (AF), the dominant issues are rate control,
anticoagulation, rhythm control, and treatment of any underlying disorder. Drug choices for …

[引用][C] Antiarrhythmic drugs

HW MOSES, PN YU - The Journal of Clinical Pharmacology, 1980 - Wiley Online Library
IN recent years major advances have occurred in the understanding and treatment of
cardiac arrhythmias. Epidemiologic studies including the use of ambulatory ECG monitoring …

心血管药物临床试验评价方法的建议

刘国仗, 吴宁, 胡大一, 陶萍, 诸骏仁, 郭林妮… - 中华心血管病 …, 1998 - cqvip.com
Ⅳ. 抗心律失常药心律失常可以发生在器质性心脏病或无明显心脏病的患者.
心律失常发生机制复杂, 临床上常分为缓慢或快速心律失常. 缓慢心律失常引起临床症状或伴有 …

[图书][B] Therapie der Herzrhythmusstörungen: Leitfaden für Klinik und Praxis

B Lüderitz - 2013 - books.google.com
Seit seinem Erscheinen hat sich" der Lüderitz" als therapeutischer Leitfaden für Klinik und
Praxis hervorragend bewährt. Das äußerst praxisorientierte Nachschlagewerk berücksichtigt …